PharmX outperforms forecasts


Pharmacy ordering platform service PharmX reports "strong start" to 2025 financial year  PharmX is reporting a 17% jump in revenue for the first half of FY2025 compared to the prior corresponding period.  The company announced that it had “outperformed forecasts” in the six months to 31 December 2024, reporting group revenues of $3.8 million.  In

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous EBOS chief sets retirement date
Next ‘How do we continue to evolve those messages?’